Earl Ettienne | Howard Profiles

See all Profiles

Faculty

Earl B. Ettienne, BScPharm, MBA, LP.D. RPh.

Assistant Dean of Graduate Programs and Industrial Partnerships

earl.ettienne@Howard.edu

Department/Office

Dean's Office

School/College

College of Pharmacy
Graduate School

Additional Positions

Associate Professor

Clinical & Administrative Pharmacy Sciences
Co-Chair Medical IRB

Research Regulatory Compliance
Member of Executive Council

Center for Women, Gender and Global Leadership

Biography

Dr. Earl B. Ettienne is a nationally recognized pharmacy executive, educator, scholar, and policy strategist whose career bridges academia, industry, government, and global health.
Currently serving as Associate Professor and Assistant Dean of Graduate Programs and Industrial Partnerships at the Howard University College of Pharmacy, Dr. Ettienne has demonstrated sustained excellence in teaching, scholarship, leadership, and service. His work embodies Howard University's mission to develop distinguished leaders who solve pressing healthcare challenges through equity, innovation, and global impact.
A licensed pharmacist with over 30 years of cross-sector experience, Dr. Ettienne has cultivated one of the nation’s most robust pipelines for minority talent in the pharmaceutical industry. As the founder and architect of the Howard University Pharmaceutical Industry Fellowship (HUPIF) Program—ranked third nationally—he has overseen the placement and development of more than 70 post-doctoral fellows across 16+ corporate partners. His visionary leadership has secured more than 35 million in grant/programmatic funding and established a graduate training ecosystem that blends rigorous scholarship, applied industry science, and culturally competent mentorship.
Dr. Ettienne’s research portfolio reflects an enduring commitment to addressing health disparities through pharmacogenomics, regulatory science, public policy, pharmacy administration and precision public health. His NIH-funded initiatives include groundbreaking work on the CYP3A4 gene’s role in opioid use disorder (OUD) among African American patients and the integration of pharmacogenomic testing into clinical decision-making for diabetes and depression. His publications—such as “Pharmacogenomics-guided policy in OUD management” and “Clinical Decision Support in an African American Cohort”—have informed clinical guidelines and influenced policy reform across multiple jurisdictions. His efforts have extended globally, including a translational pharmacogenomics pilot in Ghana that informed national prescribing practices under an NIH framework.
In the classroom, Dr. Ettienne is a transformative educator known for integrating real-world experience with academic rigor. He teaches across multiple domains including pharmacy administration, pharmacogenomics, public policy, and regulatory affairs, receiving recognition for outstanding pedagogy and translational research mentoring. His ability to connect classroom learning with global and national policy imperatives has led to multiple “Best Poster” and “Outstanding Presentation” awards at Howard University Research Day and beyond.
Dr. Ettienne is a sought-after voice in national discourse on pharmacy practice, health equity, and innovation. He has testified before Congress, advised federal and state agencies, and represented Howard University on platforms such as Bloomberg News, CNBC, WHUT, Maryland Public Television, C-SPAN, Pharmacy Times, and Chain Drug Review. He has been honoured with the Charlie Van Der Horst Sacrificial Leadership Award, the Cardinal Health GenerationRX Champions Award, and the Cultivate Leadership Award from the Young Black Pharmaceutical Professionals for his mentorship and advocacy.
His service to the academy includes his role as Co-Chair of Howard’s Institutional Review Board, President Emeritus of the Pharmacy Alumni Association, and peer reviewer for Pharmacogenomics, JAPhA, and other scholarly journals. He has led curriculum redesign efforts in pharmacy administration, making medicines, regulatory affairs and policy, and developed strategic partnerships across Africa and the Caribbean to expand Howard’s global research footprint.
A scholar with a deep sense of calling, Dr. Ettienne continues to bridge the legacy of Historically Black Colleges and Universities with the future of biomedical science, preparing students not only to enter the workforce, but to lead it.

Education

Dr. Law and Policy

LP.D.
Northeastern University
2012

Business Administration

MBA
Loyola University
2000

Pharmacy

BSc.
Howard University
1991

Expertise

Pharmacy Management, Pharmaceutical Law & Policy, Pharmacy Operations, Research, Pharmacogenomics & Policy, Business, Strategic Planning, Regulatory Affairs, Talent Development

Academics

Principles of Pharmacy Administration

This course is an expansive and in-depth Introduction to Pharmacy Administration. It facilitates the student’s management and leadership training by introducing them to a comprehensive overview of management and leadership principles, concepts and practices in pharmacy-based environments. The course further addresses the economic, administrative, entrepreneurial, innovative and human resource aspects of pharmacy practice while furthering students’ knowledge on details about the US Health Care System from a pharmacist perspective.

Pharmacy Care Management

This course is an expansive and in-depth exploration of Pharmacy Care Management within the US healthcare system. It facilitates the graduate student’s management and leadership training by introducing them to a comprehensive overview of management and leadership principles, concepts and practices in pharmacy based environments. The course further addresses the social, organizational and economic aspects of healthcare delivery while allowing the student to model real world applications. 

Making Medicines

“Making Medicines: The Process of Drug Development” is an eLearning course in collaboration with a team of academic leaders designed to deliver a scientific education curriculum highlighting the fundamental processes and rigor drug manufacturers undertake to research, develop, and deliver new medicines to patients. In this course, you will explore how a new drug is developed from the initial concept to the patient. The goal of the course is to provide an opportunity for individuals with an interest in a health-related field and medical research to learn the processes required to discover and develop drugs, that will ultimately provide a benefit to meet unmet medical needs, with minimal risk.

Pharmacy Jurisprudence

This course involves an examination of the laws and regulatory issues pertaining to the practice of pharmacy. Specifically, the course will focus on pertinent sections of the federal Controlled Substances Act, Food Drug and Cosmetic Act and other federal law, as well as an overview of pharmacy laws applicable in the District of Columbia, Maryland, and Virginia. The course is designed to assist students in preparing for and passing the MPJE.

Pharmacy Law and Policy

This is a survey course in U.S. Pharmaceutical and Health policy and law. It begins by describing the basic machinery of policymaking and legal process that underpin the individual health care and public health systems and then turns to an exploration of many of the fundamental problems and contemporary issues in pharmaceutical/health policy and law.

Research

Specialty

Pharmacy Administration, Policy, Implementation Science, Regulatory Affairs, Pharmacogenomics

Funding

HRSA 22-042 Howard University Center of Excellence (HRSA) 2022-2027

PHIT4DC The Public Health Informatics & Technology (PHIT) Workforce Development Program 2022-2025

Howard/Sanofi Postdoctoral Fellowship 2022-2025

Amgen/Howard Doctoral Fellowship- Global Regulatory Affairs and Medical Affairs 2022-2025

GlaxoSmithKline/Howard University Medical Affairs Fellowship 2022-2025

Pfizer/Howard University Global Labeling Management/Global Medical Information Fellowship 2022-2025

Jansen/Howard Fellowship Development in Medical Information/Medical Affairs/Real-World Value and Evidence 2021-2025

AbbVie/Howard Fellowship Development in Medical Affairs and Medical Information 2021-2025

AstraZeneca/Howard Fellowship Development in Medical Affairs/Oncology 2021-2025

Genentech, Fellowship Development in Regulatory Policy 2020-2025

Pharmacogenomic Decision-Making Pathway in the Optimal Management of Opioids in Patients with Sickle Cell Disease (SCD) 2021-2022

GlaxoSmithKline/Howard/FDA Regulatory Affairs/Policy Fellowship 2018-2025

District of Columbia Department of Health Care Finance (DHCF) (2018) -- Medication Assisted Treatment Genomic Registry Grant

Lilly USA Courseware Grant on Drug Development (2017-2019) -- Making Medicines: The Process of Drug Development

Howard University National Workforce Diversity Grant (Sep 2015 - Sep 2021) -- National Workforce Diversity Pipeline Program

Pfizer Regulatory Affairs Fellowship (Jul 2015 - Jul 2018) -- Designing and Implementing a Regulatory Affairs Fellowship

MHIRT (T37) Grant: NIMHD RFA-MD-13-002 (Sep 2013 - Aug 2018) -- Minority Health and Health Disparities International Research Training

Accomplishments

Chauncey I Cooper, Distinguished Alumnus Award for Outstanding Service in Pharmacy & Healthcare

Cardinal Health Generation Rx Champions Award

Washington D.C. Pharmacists Association (WDCPhA), 2018

Most Outstanding Presentation in the Area of Translational & Clinical Sciences in the Junior Faculty Category Award. Research Symposium Howard University.

Research Symposium, Howard University, 2017

Howard University College of Pharmacy Alumni Legacy by Decades" Award

Best Overall Poster Presentation

Advancing Computational Biology Symposium, Gallaudet University, 2016

Most Outstanding Presentation by a Junior Faculty Researcher

Howard University Research Day, 2014

Paragon Award for Operational Excellence

CVS/Caremark, 2005

Excellence in Execution Award

CVS/Caremark, 2003

Trailblazer Award

National Press Club, 2000

Howard Bovell Excellence in Pharmacy Award

Howard University College of Pharmacy, 1991

Upjohn Pharmaceutical Sciences Award

Howard University College of Pharmacy, 1991

Mylan Pharmaceuticals Excellence in Pharmacy Award

Howard University College of Pharmacy, 1991

Publications and Presentations

Factors Associated with Prescribing Broad-Spectrum Antibiotics for Children with Upper Respiratory Tract Infections in Ambulatory Care Settings

Alzahrani, M. S., Maneno, M. K., Daftary, M. N., Wingate, L. M., & Ettienne, E. B. (2018). Factors Associated with Prescribing Broad-Spectrum Antibiotics for Children with Upper Respiratory Tract Infections in Ambulatory Care Settings. Clinical Medicine Insights: Pediatrics, 12, 1179556518784300.

Patient perceptions of a pharmacy star rating model

Warholak, T. L., Patel, M., Rosenthal, M., West-Strum, D., Ettienne, E. B., Nunlee-Bland, G., ... & Hincapie, A. L. (2017). Patient perceptions of a pharmacy star rating model. Journal of the American Pharmacists Association, 57(3), 311-317.

Pharmacogenomics and OUD: Clinical Decision Support in an African American Cohort.

Ettienne, E. B., Ofoegbu, A., Maneno, M. K., Briggs, J., Ezeude, G., Williams, S., ... & Chapman, E. (2019). Pharmacogenomics and OUD: Clinical Decision Support in an African American Cohort. Journal of the National Medical Association.

Pharmacogenomics-guided policy in opioid use disorder (OUD) management: An ethnically-diverse case-based approach

Ettienne, E. B., Chapman, E., Maneno, M., Ofoegbu, A., Wilson, B., Settles-Reaves, B., ... & Rosenblatt, K. (2017). Pharmacogenomics-guided policy in opioid use disorder (OUD) management: An ethnically-diverse case-based approach. Addictive behaviors reports, 6, 8-14.

Opioid Metabolizing Enzyme Allele Frequencies and Drug Use in a Cohort of African American Young Adults

Wilson, B. D., Ettienne, E. B., Apprey, V., Ofeogbu, A., Abbas, M., Dunston, G. M., & Saadatmand, F. Opioid Metabolizing Enzyme Allele Frequencies and Drug Use in a Cohort of African American Young Adults.

Pharmaceutical Care Coordination and Genomics in Emerging Markets: A Business Case for Ghana.

Ettienne, E., Ofoegbu, A., Wingate, L., Dunston, G., & Augusto, J. (2015). Pharmaceutical Care Coordination and Genomics in Emerging Markets: A Business Case for Ghana. International Academy of Business Review, 1(1), 60-70.

Pharmacogenomics and Morphine.

Ofoegbu, Adaku, Ettienne, E.B. “Pharmacogenomics and Morphine. The Journal of Clinical Pharmacology. 2021 April 8, DOI: 10.1002/jcph.1873

An evaluation of hepatitis C knowledge and correlations with health belief model constructs among African American “baby boomers”

Rashrash, M. E., Maneno, M. K., Wutoh, A. K., Ettienne, E. B., & Daftary, M. N. (2016). An evaluation of hepatitis C knowledge and correlations with health belief model constructs among African American “baby boomers”. Journal of infection and public health, 9(4), 436-442.

PHP93 - FACTORS AFFECTING ADOPTION OF COMPUTERIZED PHYSICIAN ORDER ENTRY SYSTEM

Malhani, M. A., Maneno, M. K., Ettienne, E. B., Wingate, L., Lee, C., Chang, J., ... & Dagenais, S. (2016). 10. PHP93-FACTORS AFFECTING ADOPTION OF COMPUTERIZED PHYSICIAN ORDER ENTRY SYSTEM. Value in Health, 19(3), A1-A346.

Cost- effectiveness analysis of nevirapine vs. Ritonavir-boosted lopinavir in hiv-infected children with peripartum nevirapine exposure, in resource-constrained areas from a payer’s perspective

Godwin, O., Ettienne, E. B., & Brown, L. M. (2015). Cost-effectiveness analysis of nevirapine vs. Ritonavir-boosted lopinavir in hiv-infected children with peripartum nevirapine exposure, in resource-constrained areas from a payer’s perspective. Value in Health, 18(3), A240.

Evaluation of knowledge of the new Pregnancy and Lactation Labeling Rule among pharmacists and physicians.

Alem, G., Awuonda, M., Haastrup, D., Anyiwo, A., Daftary, M., & Ettienne, E. (2022). Evaluation of knowledge of the new Pregnancy and Lactation Labeling Rule among pharmacists and physicians. Journal of the American Pharmacists Association, 62(2), 427-431

Neurology’s vital role in preventing unnecessary and potentially harmful pediatric studies.

Rose, K., Ettienne, E. B., Grant-Kels, J. M., Striano, P., Neubauer, D., & Tanjinatus, O. (2022). Neurology’s vital role in preventing unnecessary and potentially harmful pediatric studies. Expert Review of Neurotherapeutics, 22(3), 209-219.

Comment on: A review of the experience with pediatric written requests issued for oncology drug products.

Rose, K., Grant-Kels, J. M., Ettienne, E. B., Tanjinatus, O., Striano, P., & Neubauer, D. Comment on: A review of the experience with pediatric written requests issued for oncology drug products. Pediatric blood & cancer, e28972.

Delayed Presentation of Non-COVID-19 Patients During the COVID-19 Pandemic Is Not Limited to Children.

Rose, K., Tanjinatus, O., Grant-Kels, J., Ettienne, E. B., & Striano, P. (2021). Delayed Presentation of Non-COVID-19 Patients During the COVID-19 Pandemic Is Not Limited to Children. Rambam Maimonides Medical Journal, 12(3)

“COVID-19 and Treatment and Immunization of Children—The Time to Redefine Pediatric Age Groups is Here”

Rose, K., Grant-Kels, J., Ettienne, E., Tanjinatus, O., Striano, P., & Neubauer, D. “COVID-19 and Treatment and Immunization of Children—The Time to Redefine Pediatric Age Groups is Here” 2021 March 25 Rambam Maimonides Medical Journal

“Comment on: A review of the experience with pediatric written requests issued for oncology drug products

Rose, K., Grant-Kels, J., Ettienne, E., Tanjinatus, O., Striano, P., & Neubauer, D. (2021). “Comment on: A review of the experience with pediatric written requests issued for oncology drug products. Pediatric Blood & Cancer 2021 February 22 https://doi.org/10.1002/pbc.28972

The Term “Juvenile Idiopathic Arthritis (JIA)” is Misleading. It Will not be Sufficient to Just Replace this Term.

Rose, K., Tanjinatus, O., & Ettienne, E. B. (2021). The Term “Juvenile Idiopathic Arthritis (JIA)” is Misleading. It Will not be Sufficient to Just Replace this Term. Pharmaceutical Medicine 2021, January 16 https://doi.org/10.1007/s40290-021-00379-8

“Minors and a Dawning Paradigm Shift in “Pediatric” Drug Development”. The Journal of Clinical Pharmacology

Rose, K., Tanjinatus, O., Grant‐Kels, J., Ettienne, E. B., Striano, P., & Neubauer, D. “Minors and a Dawning Paradigm Shift in “Pediatric” Drug Development”. The Journal of Clinical Pharmacology, 2020 December, 23

Patterns of Hepatitis C-Related Inpatient Mortality in the United States in the Era of Direct-Acting Antivirals.

Alzarani MS, Maneno MK, Daftary MN, Wingate LT, Ettienne EB, Howell CD. Patterns of Hepatitis C-Related Inpatient Mortality in the United States in the Era of Direct-Acting Antivirals. Journal of Gastroenterology and Hepatology Research 2020 June 21; 9(3): 1-7.

Development and Validation of Amharic Version of the Simplified Medication Adherence Questionnaire among Literate Amharic Speaking Persons an Urban Teaching Hospital.

Al Matari RA, Maneno MK, Daftary MN, Wingate LT, Ettienne EB. Development and Validation of Amharic Version of the Simplified Medication Adherence Questionnaire among Literate Amharic Speaking Persons an Urban Teaching Hospital. Int J Case Rep Short Rev. 2019; 5(1): 001-005.

The Economic Impact of Herpes Zoster Vaccine Disparities in Elderly United States Blacks.

Wingate, L., Stubbs, K., Ahmed, I., Mayaka, R., Maneno, M., Ettienne, E., Elekwachi, O., et al. (2018). The Economic Impact of Herpes Zoster Vaccine Disparities in Elderly United States Blacks. International Journal of Environmental Research and Public Health, 15(10), 2128. MDPI AG. Retrieved from http://dx.doi.org/10.3390/ijerph15102128

Evaluation of Adherence and its Predictors Among Persons of Ethiopian Descent in Washington DC.

AL-Matari, R. A., Maneno, M. K., Daftary, M., Ettienne, E. B., Wingate, L. T., & Hailemeskel, B. (2018). Evaluation of Adherence and its Predictors Among Persons of Ethiopian Descent in Washington DC. Value in Health, 21, S112.

Public choice theory and rhetoric: advancing pharmacogenomics through health policy in Africa.

Ettienne, E., Ofoegbu, A., Maneno, M., Dunston, G., Kurian, P., Wilson, B. D... & Augusto, J. (2017). Public choice theory and rhetoric: advancing pharmacogenomics through health policy in Africa. African Journal of Rhetoric, 9(1), 119-142.

Hybrid e-learning approach to health policy

Weaver, S. B., Oji, V., Ettienne, E., Stolpe, S., & Maneno, M. (2014). Hybrid e-learning approach to health policy. Currents in Pharmacy Teaching and Learning, 6(2), 313-322.